COL3A1 and Ehlers-Danlos syndrome: Molecular and clinical qualification appropriately assigns a 4+ diagnostic utility to the COL3A1-FLG variant combination, with the symptom pattern favoring hypermobile EDS even though frequent associations of COL3A1 variants with vascular EDS (M130050) might add screening for aneurysms to its usual management.